# Lithium Americas Corp.: financial statements, quarterly

LAC · NYSE · CIK 1966983 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lac.md) · [Financials](/companies/lac/financials.md) · [Filings](/companies/lac/filings.md) · [Insiders](/companies/lac/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/lac/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [0.0](/filings/0000950170-25-071963.md) | [0.0](/filings/0000950170-25-108408.md) | [0.0](/filings/0001193125-25-278738.md) | [(0.0) d](/filings/0000950170-25-046424.md) | [0.0](/filings/0000950170-25-071963.md) | [0.0](/filings/0000950170-25-108408.md) | [0.0](/filings/0001193125-25-278738.md) | not reported | not reported | not reported |
| Net income | $m | [(6.3)](/filings/0001193125-25-278738.md) | [(6.6)](/filings/0001193125-25-278738.md) | [(8.5)](/filings/0001193125-25-278738.md) | [(21.3) d](/filings/0001193125-26-115081.md) | [(11.5)](/filings/0001193125-26-347826.md) | [(13.2)](/filings/0001193125-26-347826.md) | [(199)](/filings/0001193125-25-278738.md) | [138 d](/filings/0001193125-26-115081.md) | [4.6](/filings/0001193125-26-347826.md) | [1.7](/filings/0001193125-26-347826.md) |
| Diluted EPS | $ per share | [(0.04)](/filings/0000950170-25-071963.md) | [(0.03)](/filings/0000950170-25-108408.md) | [(0.04)](/filings/0001193125-25-278738.md) | not reported | [(0.05)](/filings/0001193125-26-222727.md) | [(0.06)](/filings/0001193125-26-347826.md) | [(0.83)](/filings/0001193125-25-278738.md) | not reported | [0.00](/filings/0001193125-26-222727.md) | [(0.02)](/filings/0001193125-26-347826.md) |
| Basic EPS | $ per share | [(0.04)](/filings/0000950170-25-071963.md) | [(0.03)](/filings/0000950170-25-108408.md) | [(0.04)](/filings/0001193125-25-278738.md) | not reported | [(0.05)](/filings/0001193125-26-222727.md) | [(0.06)](/filings/0001193125-26-347826.md) | [(0.83)](/filings/0001193125-25-278738.md) | not reported | [0.00](/filings/0001193125-26-222727.md) | [0.01](/filings/0001193125-26-347826.md) |

- Interest expense: us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2022-12-31) | FY2023 (2023-12-31) | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.6](/filings/0000950170-24-032515.md) | [196](/filings/0000950170-25-046424.md) | not reported | not reported | not reported | [594](/filings/0001193125-26-115081.md) | [447](/filings/0000950170-25-071963.md) | [509](/filings/0000950170-25-108408.md) | [385](/filings/0001193125-25-278738.md) | [568](/filings/0001193125-26-347826.md) | [759](/filings/0001193125-26-222727.md) | [823](/filings/0001193125-26-347826.md) |
| Current assets | $m | [1.9](/filings/0000950170-24-032515.md) | [206](/filings/0000950170-25-046424.md) | not reported | not reported | not reported | [602](/filings/0001193125-26-115081.md) | [449](/filings/0000950170-25-071963.md) | [512](/filings/0000950170-25-108408.md) | [389](/filings/0001193125-25-278738.md) | [912](/filings/0001193125-26-347826.md) | [1,212](/filings/0001193125-26-222727.md) | [1,282](/filings/0001193125-26-347826.md) |
| Total assets | $m | [27.8](/filings/0000950170-24-032515.md) | [437](/filings/0000950170-25-046424.md) | not reported | not reported | not reported | [1,045](/filings/0001193125-26-115081.md) | [1,018](/filings/0000950170-25-071963.md) | [1,339](/filings/0000950170-25-108408.md) | [1,452](/filings/0001193125-25-278738.md) | [2,579](/filings/0001193125-26-347826.md) | [3,113](/filings/0001193125-26-222727.md) | [3,536](/filings/0001193125-26-347826.md) |
| Current liabilities | $m | [54.2](/filings/0000950170-24-032515.md) | [24.6](/filings/0000950170-25-046424.md) | not reported | not reported | not reported | [58.3](/filings/0001193125-26-115081.md) | [43.4](/filings/0000950170-25-071963.md) | [51.8](/filings/0000950170-25-108408.md) | [103](/filings/0001193125-25-278738.md) | [177](/filings/0001193125-26-347826.md) | [165](/filings/0001193125-26-222727.md) | [235](/filings/0001193125-26-347826.md) |
| Total liabilities | $m | [62.3](/filings/0000950170-24-032515.md) | [52.0](/filings/0000950170-25-046424.md) | not reported | not reported | not reported | [99.6](/filings/0001193125-26-115081.md) | [83.5](/filings/0000950170-25-071963.md) | [303](/filings/0000950170-25-108408.md) | [555](/filings/0001193125-25-278738.md) | [992](/filings/0001193125-26-347826.md) | [1,236](/filings/0001193125-26-222727.md) | [1,586](/filings/0001193125-26-347826.md) |
| Shareholders' equity | $m | [(55.8)](/filings/0000950170-25-046424.md) | [385](/filings/0000950170-25-046424.md) | [384](/filings/0001193125-25-278738.md) | [642](/filings/0001193125-25-278738.md) | [635](/filings/0001193125-25-278738.md) | [635](/filings/0001193125-26-115081.md) | [626](/filings/0000950170-25-071963.md) | [616](/filings/0000950170-25-108408.md) | [476](/filings/0001193125-25-278738.md) | [1,059](/filings/0001193125-26-347826.md) | [1,344](/filings/0001193125-26-222727.md) | [1,417](/filings/0001193125-26-347826.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: ifrs-full:CurrentAssets, us-gaap:AssetsCurrent
- Total assets: ifrs-full:Assets, us-gaap:Assets
- Current liabilities: ifrs-full:CurrentLiabilities, us-gaap:LiabilitiesCurrent
- Total liabilities: ifrs-full:Liabilities, us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(2.2)](/filings/0000950170-25-071963.md) | [(2.6) d](/filings/0000950170-25-108408.md) | [0.1 d](/filings/0001193125-25-278738.md) | [(8.3) d](/filings/0001193125-26-115081.md) | [(18.8)](/filings/0001193125-26-222727.md) | [(30.5) d](/filings/0001193125-26-347826.md) | [2.3 d](/filings/0001193125-25-278738.md) | [(14.2) d](/filings/0001193125-26-115081.md) | [(18.3)](/filings/0001193125-26-222727.md) | [(5.6) d](/filings/0001193125-26-347826.md) |
| Capital expenditure | $m | [46.1](/filings/0000950170-25-071963.md) | [31.0 d](/filings/0000950170-25-108408.md) | [34.7 d](/filings/0001193125-25-278738.md) | [66.0 d](/filings/0001193125-26-115081.md) | [118](/filings/0001193125-26-222727.md) | [236 d](/filings/0001193125-26-347826.md) | [172 d](/filings/0001193125-25-278738.md) | [239 d](/filings/0001193125-26-115081.md) | [299](/filings/0001193125-26-222727.md) | [332 d](/filings/0001193125-26-347826.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2024-03-31) | period not labelled (2024-06-30) | period not labelled (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [162](/filings/0000950170-25-071963.md) | [204](/filings/0000950170-25-108408.md) | [218](/filings/0001193125-25-278738.md) | [219](/filings/0001193125-26-222727.md) | [220](/filings/0001193125-26-347826.md) | [239](/filings/0001193125-25-278738.md) | [353](/filings/0001193125-26-222727.md) | [402](/filings/0001193125-26-347826.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 363,042,943 at 2026-08-12, from the cover of the [10-Q filed 2026-08-13](/filings/0001193125-26-347826.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.